Diagnosed Prevalence of Alzheimer's Disease and Related Dementias in Medicare Advantage Plans

    Details
    Basic Details
    Date
    Sunday, July 5, 2020
    Entity
    NIH
    Type
    Publication
    Description

    One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date.

    Contributors
    Author(s)

    Eric Jutkowitz, Julie P. W. Bynum, Susan L. Mitchell, Noelle M. Cocoros, Oren Shapira, Kevin Haynes, Vinit P. Nair, Cheryl N. McMahill‐Walraven, Richard Platt, Ellen P. McCarthy